| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |